CD3 epsilon

CD3 epsilon

CD3 epsilon 분자 정보

Molecule Name
T-cell surface glycoprotein CD3 epsilon chain
분자 별명
FLJ18683,T3E,TCRE,CD3E,CD3-epsilon
Drug Development Progress
임상 약물 수7
시판 약물 수4
최고 연구 개발 단계Approved
표적 별명
T-cell surface antigen T3/Leu-4 epsilon chain,CD3-Epsilon
분자 배경
CD3e molecule, epsilon is also known as CD3E, is a T-cell surface single-pass type I membrane glycoprotein. CD3E contains 1 Ig-like (immunoglobulin-like) domain and 1 ITAM domain. CD3E, together with CD3-gamma, CD3-delta and CD3-zeta, and the T-cell receptor alpha/beta and gamma/delta heterodimers, forms the T cell receptor-CD3 complex. This complex plays an important role in coupling antigen recognition to several intracellular signal-transduction pathways. The genes encoding the epsilon, gamma and delta polypeptides are located in the same cluster on chromosome 11. The epsilon polypeptide plays an essential role in T-cell development. CD3E plays an essential role in T-cell development, and defects in CD3E gene cause severe immunodeficiency. CD3E gene has also been linked to a susceptibility to type I diabetes in women. CD3E has been shown to interact with TOP2B, CD3EAP and NCK2.

CD3 epsilon 제품 목록

No Data
You Have Viewed 0 Of 0 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

임상 약물 정보

영어 이름연구 코드연구 개발 단계회사적응증임상 시험
ForalumabNI-0401/α-CD3; TZLS-401; NI-0401Phase 2 ClinicalMedarex Inc, Novimmune Sa
Alzheimer Disease; Amyotrophic Lateral Sclerosis; Cognitive Dysfunction; Coronavirus Disease 2019 (COVID-19); Crohn Disease; Dementia; Diabetes Mellitus, Type 2; Lower Respiratory Tract Infections; Metabolic Dysfunction-Associated Steatotic Liver Disease; Multiple Sclerosis; Multiple Sclerosis, Chronic Progressive; Multiple System Atrophy; Rejection of renal transplantation
상세
ObrindatamabMGD-009; B7-H3 x CD3Phase 2 ClinicalMacrogenics Inc
Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Colonic Neoplasms; Melanoma; Mesothelioma; Neuroblastoma; Neurofibrosarcoma; Ovarian Neoplasms; Pancreatic Neoplasms; Prostatic Neoplasms; Rhabdomyosarcoma; Sarcoma; Sarcoma, Synovial; Squamous Cell Carcinoma of Head and Neck; Thyroid Neoplasms; Urinary Bladder Neoplasms; Wilms Tumor
상세
SOA-101SOA-101; SOA101Phase 2 ClinicalShine-On BioMedical Co Ltd
Brain Neoplasms; Breast Neoplasms; Lung Neoplasms; Mouth Neoplasms; Ovarian Neoplasms; Solid tumours
상세
EmerfetamabAMG-673; AMG673Phase 1 ClinicalAmgen Inc
Leukemia, Myeloid, Acute
상세
GresonitamabAMG-910Phase 1 ClinicalAmgen Inc
Adenocarcinoma; Esophageal Neoplasms; Stomach Neoplasms
상세
EluvixtamabAMG-330; MT-114Phase 1 ClinicalAmgen Inc
Leukemia, Myeloid, Acute; Myelodysplastic Syndromes
상세
LinclatamigBLYG-8824; BLYG-8824A; RG 6286Phase 1 ClinicalGenentech Inc
Colorectal Neoplasms
상세

시판 약물 정보

영어 이름연구 코드연구 개발 단계회사가장 빠른 브랜드 이름가장 빠른 승인 국가가장 빠른 적응증가장 빠른 승인 회사가장 빠른 승인 날짜적응증임상 시험
TarlatamabAMG-757ApprovedAmgen IncImdelltraUnited StatesSmall Cell Lung CarcinomaAmgen Inc2024-05-16
Astrocytoma; Brain metastases; Carcinoma, Merkel Cell; Carcinoma, Neuroendocrine; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Ganglioglioma; Glioblastoma; Medullary thyroid cancer (MTC); Melanoma; Neoplasms; Neuroendocrine Tumors; Oligodendroglioma; Paranasal Sinus Diseases; Prostatic Neoplasms; Small Cell Lung Carcinoma; Testicular Neoplasms; Urinary Bladder Neoplasms; Uterine Cervical Neoplasms
상세
ElranatamabPF‑3135; RN-613; PF-06863135ApprovedPfizer IncElrexfio, ELREXFIO™, ELREXFIOUnited StatesMultiple MyelomaPfizer Inc2023-08-14
Anemia, Hemolytic, Autoimmune; Bone Marrow Neoplasms; Immunoglobulin Light-chain Amyloidosis; Multiple Myeloma; Smoldering Multiple Myeloma; Spinal Cord Diseases
상세
GlofitamabRG-6026; RO-7082859; RG6026-2; RO6026ApprovedF. Hoffmann-La Roche LtdCOLUMVI, 高罗华CanadaLymphoma, Large B-Cell, DiffuseF. Hoffmann-La Roche Ltd2023-03-25
Central Nervous System Lymphoma; Lymphoma; Lymphoma, B-Cell; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Mantle-Cell; Lymphoma, Non-Hodgkin
상세
TalquetamabJNJ-7564; JNJ-64407564ApprovedGenmab A/S, Johnson & Johnson Innovative MedicineTALVEY, 拓立珂United StatesMultiple MyelomaJanssen Biotech Inc2023-08-09
Hematologic Neoplasms; Multiple Myeloma
상세